menu
    • menu

    Company profile for Capricor Therapeutics

    NEW Drugs in Dev: 5
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapeutics for the treatment of rare disorders. Our innovative technology builds upon a large body of scientific research and enables us to approach the treatment of diseases in novel ways.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Capricor TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    8840 Wilshire Blvd 2nd Floor Beverly Hills, CA 90211
    Telephone
    Telephone
    +310-358-3200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://capricor.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Capricor Therapeutics Reports Q1 2026 Results and Corporate
    Capricor Therapeutics Reports Q1 2026 Results and Corporate

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3293375/0/en/capricor-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    Capricor Sues Nippon Shinyaku Over Duchenne Drug Price Flaw
    Capricor Sues Nippon Shinyaku Over Duchenne Drug Price Flaw

    08 May 2026

    // ENDPOINTS

    https://endpoints.news/capricor-sues-nippon-shinyaku-over-duchenne-drug-pricing-flaw-and-launch-prep/

    ENDPOINTS
    08 May 2026
    Share Share
    Capricor Therapeutics to Report Q1 2026 Results on May 12
    Capricor Therapeutics to Report Q1 2026 Results on May 12

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3287147/0/en/capricor-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-recent-corporate-update-on-may-12.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    Capricor Therapeutics Unveils HOPE-3 Phase 3 Results At AAN 2026
    Capricor Therapeutics Unveils HOPE-3 Phase 3 Results At AAN 2026

    22 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/22/3279030/0/en/capricor-therapeutics-announces-late-breaking-presentation-of-hope-3-phase-3-results-at-the-american-academy-of-neurology-2026-annual-meeting.html

    GLOBENEWSWIRE
    22 Apr 2026
    Share Share
    Capricor Therapeutics Announces Late-Breaking HOPE-3 Data
    Capricor Therapeutics Announces Late-Breaking HOPE-3 Data

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254704/0/en/Capricor-Therapeutics-Announces-Late-Breaking-HOPE-3-Data-at-the-2026-MDA-Conference-Demonstrating-Significant-Functional-Benefits-of-Deramiocel-for-Duchenne-Muscular-Dystrophy.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Capricor Therapeutics Reports Q4 & FY 2025 Results
    Capricor Therapeutics Reports Q4 & FY 2025 Results

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3255084/0/en/Capricor-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search